Join Medical Marketing Whiz and Walt Eckert of Blue & Co., as they discuss How Outsourcing Can Grow Your Practice. You’re going to learn: Learn when it is the right […]
Read More
The most significant tax-related executive action is the “Memorandum on Deferring Payroll Tax Obligations in Light of the Ongoing COVID-19 Disaster.” Taxpayer be wary, this order does not revoke your […]
Read More
On September 2, 2020, CMS released its final ruling. It is effective beginning October 1, 2020, for FY 2021. This means it will go in to effect the first day […]
Read More
340B covered entities have likely felt bombarded during the last few weeks with various letters from manufacturers, word of additional cuts in Medicare part B drug reimbursement for some hospitals, […]
Read More
Join Medical Marketing Whiz and Tom Skoog of Blue & Co., as they discuss Cybersecurity: 5 Action Steps to Protect Your Practice. A lack of focus on cybersecurity can be […]
Read More
Guidance on Related Party Rent In this Interim Final Rule, the SBA addressed three issues many companies face. The most significant is related party rent. C corporations and S corporations. […]
Read More
AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their […]
Read More
COVID-19 has added several new tax challenges to everyone’s plate this year. One of the less commonly discussed problems has been the impact of the sudden increase of remote workers […]
Read More
On Saturday, August 8th, President Donald Trump signed four executive actions relating to COVID-19 relief. The orders provide for a payroll tax deferment, an extension of the deferment of student […]
Read More
Did you know that as of March 27, 2020, most Required Minimum Distributions (RMDs) were waived for the 2020 calendar year? That means that if you normally take an RMD […]
Read More
On August 28, 2026, the U.S. District Court for the District of Columbia vacated CMS’s 2023 rule addressing the treatment of Medicare Advantage (Part C) inpatient days in the Medicare […]
By Stephen Stringer, CPA, Director at Blue & Co. If there is one thing most plastic processors can agree on, it’s that operating a plastic manufacturing business has become increasingly […]
By Becca Meredith, CPA, FHFMA, Senior Manager at Blue & Co. For Medicare cost reporting periods ending on or after January 1, 2026, many acute care hospitals will have to […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
